Bromine in PDB 6tlr: Human CK2 Kinase Alpha Subunit in Complex with the Atp-Competitive Inhibitor 4,7-Dibromobenzotriazole
Enzymatic activity of Human CK2 Kinase Alpha Subunit in Complex with the Atp-Competitive Inhibitor 4,7-Dibromobenzotriazole
All present enzymatic activity of Human CK2 Kinase Alpha Subunit in Complex with the Atp-Competitive Inhibitor 4,7-Dibromobenzotriazole:
2.7.11.1;
Protein crystallography data
The structure of Human CK2 Kinase Alpha Subunit in Complex with the Atp-Competitive Inhibitor 4,7-Dibromobenzotriazole, PDB code: 6tlr
was solved by
H.Czapinska,
A.Piasecka,
M.Winiewska-Szajewska,
M.Bochtler,
J.Poznanski,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
44.28 /
1.64
|
Space group
|
P 42 21 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
128.326,
128.326,
61.192,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
14.9 /
17.8
|
Other elements in 6tlr:
The structure of Human CK2 Kinase Alpha Subunit in Complex with the Atp-Competitive Inhibitor 4,7-Dibromobenzotriazole also contains other interesting chemical elements:
Bromine Binding Sites:
The binding sites of Bromine atom in the Human CK2 Kinase Alpha Subunit in Complex with the Atp-Competitive Inhibitor 4,7-Dibromobenzotriazole
(pdb code 6tlr). This binding sites where shown within
5.0 Angstroms radius around Bromine atom.
In total 6 binding sites of Bromine where determined in the
Human CK2 Kinase Alpha Subunit in Complex with the Atp-Competitive Inhibitor 4,7-Dibromobenzotriazole, PDB code: 6tlr:
Jump to Bromine binding site number:
1;
2;
3;
4;
5;
6;
Bromine binding site 1 out
of 6 in 6tlr
Go back to
Bromine Binding Sites List in 6tlr
Bromine binding site 1 out
of 6 in the Human CK2 Kinase Alpha Subunit in Complex with the Atp-Competitive Inhibitor 4,7-Dibromobenzotriazole
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 1 of Human CK2 Kinase Alpha Subunit in Complex with the Atp-Competitive Inhibitor 4,7-Dibromobenzotriazole within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Br401
b:59.4
occ:0.70
|
BR1
|
A:NKE401
|
0.0
|
59.4
|
0.7
|
BR1
|
A:NKE401
|
0.7
|
93.9
|
0.3
|
C4
|
A:NKE401
|
1.9
|
46.0
|
0.7
|
C4
|
A:NKE401
|
2.5
|
75.0
|
0.3
|
C6
|
A:NKE401
|
2.9
|
41.9
|
0.7
|
C1
|
A:NKE401
|
2.9
|
42.5
|
0.7
|
OD1
|
A:ASN118
|
3.0
|
62.5
|
1.0
|
C6
|
A:NKE401
|
3.3
|
72.1
|
0.3
|
O
|
A:HOH805
|
3.3
|
73.5
|
1.0
|
N5
|
A:NKE401
|
3.3
|
43.0
|
0.7
|
N5
|
A:NKE401
|
3.5
|
70.5
|
0.3
|
C1
|
A:NKE401
|
3.5
|
72.2
|
0.3
|
O
|
A:HOH708
|
3.7
|
35.0
|
0.3
|
CE
|
A:MET163
|
3.9
|
42.9
|
1.0
|
CG
|
A:ASN118
|
3.9
|
57.5
|
1.0
|
O
|
A:HOH736
|
3.9
|
49.5
|
0.7
|
O
|
A:HOH563
|
4.0
|
61.4
|
1.0
|
C7
|
A:NKE401
|
4.2
|
40.5
|
0.7
|
C2
|
A:NKE401
|
4.2
|
43.0
|
0.7
|
CG1
|
A:VAL53
|
4.4
|
36.6
|
1.0
|
CE1
|
A:HIS160
|
4.5
|
43.7
|
0.7
|
CA
|
A:GLY46
|
4.5
|
56.9
|
1.0
|
ND2
|
A:ASN118
|
4.5
|
58.5
|
1.0
|
CB
|
A:VAL53
|
4.5
|
37.9
|
1.0
|
N
|
A:GLY46
|
4.6
|
50.5
|
1.0
|
CB
|
A:LEU45
|
4.6
|
42.2
|
1.0
|
N9
|
A:NKE401
|
4.6
|
40.5
|
0.7
|
C7
|
A:NKE401
|
4.7
|
67.7
|
0.3
|
NE2
|
A:HIS160
|
4.7
|
43.7
|
0.7
|
C
|
A:LEU45
|
4.7
|
48.7
|
1.0
|
C3
|
A:NKE401
|
4.7
|
38.8
|
0.7
|
CG2
|
A:VAL53
|
4.7
|
38.9
|
1.0
|
CB
|
A:ASN118
|
4.8
|
54.1
|
1.0
|
O
|
A:LEU45
|
4.8
|
52.0
|
1.0
|
C2
|
A:NKE401
|
4.8
|
68.0
|
0.3
|
N9
|
A:NKE401
|
4.9
|
68.9
|
0.3
|
|
Bromine binding site 2 out
of 6 in 6tlr
Go back to
Bromine Binding Sites List in 6tlr
Bromine binding site 2 out
of 6 in the Human CK2 Kinase Alpha Subunit in Complex with the Atp-Competitive Inhibitor 4,7-Dibromobenzotriazole
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 2 of Human CK2 Kinase Alpha Subunit in Complex with the Atp-Competitive Inhibitor 4,7-Dibromobenzotriazole within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Br401
b:93.9
occ:0.30
|
BR1
|
A:NKE401
|
0.0
|
93.9
|
0.3
|
BR1
|
A:NKE401
|
0.7
|
59.4
|
0.7
|
C4
|
A:NKE401
|
1.3
|
46.0
|
0.7
|
C4
|
A:NKE401
|
1.9
|
75.0
|
0.3
|
C6
|
A:NKE401
|
2.2
|
41.9
|
0.7
|
C1
|
A:NKE401
|
2.4
|
42.5
|
0.7
|
N5
|
A:NKE401
|
2.8
|
43.0
|
0.7
|
C6
|
A:NKE401
|
2.9
|
72.1
|
0.3
|
C1
|
A:NKE401
|
2.9
|
72.2
|
0.3
|
N5
|
A:NKE401
|
3.3
|
70.5
|
0.3
|
OD1
|
A:ASN118
|
3.4
|
62.5
|
1.0
|
C7
|
A:NKE401
|
3.5
|
40.5
|
0.7
|
C2
|
A:NKE401
|
3.6
|
43.0
|
0.7
|
CE
|
A:MET163
|
3.7
|
42.9
|
1.0
|
O
|
A:HOH805
|
3.7
|
73.5
|
1.0
|
O
|
A:HOH708
|
3.8
|
35.0
|
0.3
|
O
|
A:HOH736
|
3.8
|
49.5
|
0.7
|
C3
|
A:NKE401
|
4.0
|
38.8
|
0.7
|
N9
|
A:NKE401
|
4.1
|
40.5
|
0.7
|
C7
|
A:NKE401
|
4.1
|
67.7
|
0.3
|
CG1
|
A:VAL53
|
4.2
|
36.6
|
1.0
|
C2
|
A:NKE401
|
4.2
|
68.0
|
0.3
|
CG
|
A:ASN118
|
4.2
|
57.5
|
1.0
|
O
|
A:HOH563
|
4.4
|
61.4
|
1.0
|
N8
|
A:NKE401
|
4.4
|
39.9
|
0.7
|
CB
|
A:VAL53
|
4.4
|
37.9
|
1.0
|
CG2
|
A:VAL53
|
4.6
|
38.9
|
1.0
|
N9
|
A:NKE401
|
4.6
|
68.9
|
0.3
|
CD1
|
A:ILE174
|
4.7
|
28.4
|
1.0
|
C3
|
A:NKE401
|
4.7
|
65.5
|
0.3
|
CE1
|
A:HIS160
|
4.7
|
43.7
|
0.7
|
NE2
|
A:HIS160
|
4.8
|
43.7
|
0.7
|
CB
|
A:LEU45
|
4.9
|
42.2
|
1.0
|
CB
|
A:ASN118
|
5.0
|
54.1
|
1.0
|
ND2
|
A:ASN118
|
5.0
|
58.5
|
1.0
|
|
Bromine binding site 3 out
of 6 in 6tlr
Go back to
Bromine Binding Sites List in 6tlr
Bromine binding site 3 out
of 6 in the Human CK2 Kinase Alpha Subunit in Complex with the Atp-Competitive Inhibitor 4,7-Dibromobenzotriazole
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 3 of Human CK2 Kinase Alpha Subunit in Complex with the Atp-Competitive Inhibitor 4,7-Dibromobenzotriazole within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Br401
b:41.2
occ:0.70
|
BR2
|
A:NKE401
|
0.0
|
41.2
|
0.7
|
C3
|
A:NKE401
|
1.9
|
38.8
|
0.7
|
C2
|
A:NKE401
|
2.7
|
68.0
|
0.3
|
C7
|
A:NKE401
|
2.8
|
40.5
|
0.7
|
C2
|
A:NKE401
|
2.9
|
43.0
|
0.7
|
C1
|
A:NKE401
|
3.3
|
72.2
|
0.3
|
N8
|
A:NKE401
|
3.3
|
39.9
|
0.7
|
CD1
|
A:ILE95
|
3.7
|
30.7
|
1.0
|
CG1
|
A:ILE95
|
3.7
|
29.8
|
1.0
|
C3
|
A:NKE401
|
3.8
|
65.5
|
0.3
|
CG2
|
A:VAL116
|
3.9
|
44.4
|
1.0
|
O
|
A:HOH814
|
4.0
|
24.8
|
0.7
|
CD2
|
A:PHE113
|
4.0
|
24.9
|
1.0
|
CG
|
A:PHE113
|
4.1
|
24.1
|
1.0
|
CG2
|
A:ILE174
|
4.1
|
27.0
|
1.0
|
CG1
|
A:VAL66
|
4.1
|
31.0
|
1.0
|
C6
|
A:NKE401
|
4.1
|
41.9
|
0.7
|
CB
|
A:PHE113
|
4.2
|
24.2
|
1.0
|
C1
|
A:NKE401
|
4.2
|
42.5
|
0.7
|
BR2
|
A:NKE401
|
4.4
|
53.3
|
0.3
|
CB
|
A:VAL66
|
4.4
|
29.6
|
1.0
|
N9
|
A:NKE401
|
4.6
|
40.5
|
0.7
|
CB
|
A:ILE174
|
4.6
|
25.7
|
1.0
|
C4
|
A:NKE401
|
4.6
|
75.0
|
0.3
|
CE2
|
A:PHE113
|
4.6
|
25.7
|
1.0
|
C4
|
A:NKE401
|
4.7
|
46.0
|
0.7
|
CG2
|
A:VAL66
|
4.7
|
31.5
|
1.0
|
CD1
|
A:PHE113
|
4.8
|
25.1
|
1.0
|
CB
|
A:ILE95
|
4.9
|
27.7
|
1.0
|
N5
|
A:NKE401
|
5.0
|
43.0
|
0.7
|
|
Bromine binding site 4 out
of 6 in 6tlr
Go back to
Bromine Binding Sites List in 6tlr
Bromine binding site 4 out
of 6 in the Human CK2 Kinase Alpha Subunit in Complex with the Atp-Competitive Inhibitor 4,7-Dibromobenzotriazole
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 4 of Human CK2 Kinase Alpha Subunit in Complex with the Atp-Competitive Inhibitor 4,7-Dibromobenzotriazole within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Br401
b:53.3
occ:0.30
|
BR2
|
A:NKE401
|
0.0
|
53.3
|
0.3
|
O
|
A:HOH814
|
1.3
|
24.8
|
0.7
|
C3
|
A:NKE401
|
1.9
|
65.5
|
0.3
|
N8
|
A:NKE401
|
2.3
|
39.9
|
0.7
|
N9
|
A:NKE401
|
2.6
|
40.5
|
0.7
|
C7
|
A:NKE401
|
2.8
|
67.7
|
0.3
|
C2
|
A:NKE401
|
2.9
|
68.0
|
0.3
|
N
|
A:ASP175
|
3.3
|
24.9
|
1.0
|
N8
|
A:NKE401
|
3.3
|
68.2
|
0.3
|
NZ
|
A:LYS68
|
3.4
|
40.7
|
1.0
|
CA
|
A:ASP175
|
3.4
|
26.4
|
1.0
|
O
|
A:HOH652
|
3.4
|
28.1
|
1.0
|
O
|
A:HOH567
|
3.5
|
66.0
|
0.7
|
C7
|
A:NKE401
|
3.6
|
40.5
|
0.7
|
CD
|
A:LYS68
|
3.7
|
40.9
|
1.0
|
N5
|
A:NKE401
|
4.0
|
43.0
|
0.7
|
CB
|
A:ASP175
|
4.0
|
29.1
|
1.0
|
CE
|
A:LYS68
|
4.0
|
42.0
|
1.0
|
C6
|
A:NKE401
|
4.1
|
72.1
|
0.3
|
C1
|
A:NKE401
|
4.2
|
72.2
|
0.3
|
CE2
|
A:PHE113
|
4.2
|
25.7
|
1.0
|
CB
|
A:ILE174
|
4.2
|
25.7
|
1.0
|
CZ
|
A:PHE113
|
4.3
|
25.6
|
1.0
|
BR2
|
A:NKE401
|
4.4
|
41.2
|
0.7
|
CG
|
A:ASP175
|
4.4
|
34.0
|
1.0
|
C
|
A:ILE174
|
4.4
|
24.0
|
1.0
|
C6
|
A:NKE401
|
4.4
|
41.9
|
0.7
|
C3
|
A:NKE401
|
4.5
|
38.8
|
0.7
|
OD1
|
A:ASP175
|
4.5
|
31.6
|
1.0
|
CD1
|
A:ILE174
|
4.6
|
28.4
|
1.0
|
N9
|
A:NKE401
|
4.6
|
68.9
|
0.3
|
C4
|
A:NKE401
|
4.7
|
75.0
|
0.3
|
C
|
A:ASP175
|
4.7
|
25.1
|
1.0
|
CA
|
A:ILE174
|
4.7
|
24.1
|
1.0
|
OE2
|
A:GLU81
|
4.8
|
30.1
|
1.0
|
CG
|
A:LYS68
|
4.8
|
38.4
|
1.0
|
N
|
A:TRP176
|
4.9
|
26.0
|
1.0
|
CG1
|
A:ILE174
|
4.9
|
26.0
|
1.0
|
CD2
|
A:PHE113
|
4.9
|
24.9
|
1.0
|
|
Bromine binding site 5 out
of 6 in 6tlr
Go back to
Bromine Binding Sites List in 6tlr
Bromine binding site 5 out
of 6 in the Human CK2 Kinase Alpha Subunit in Complex with the Atp-Competitive Inhibitor 4,7-Dibromobenzotriazole
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 5 of Human CK2 Kinase Alpha Subunit in Complex with the Atp-Competitive Inhibitor 4,7-Dibromobenzotriazole within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Br402
b:55.5
occ:0.60
|
BR1
|
A:NKE402
|
0.0
|
55.5
|
0.6
|
C4
|
A:NKE402
|
1.9
|
59.1
|
0.6
|
O
|
A:HOH837
|
2.9
|
24.0
|
0.4
|
C1
|
A:NKE402
|
2.9
|
60.2
|
0.6
|
C6
|
A:NKE402
|
2.9
|
60.8
|
0.6
|
O
|
A:ASN117
|
2.9
|
44.6
|
1.0
|
O
|
A:HOH530
|
3.2
|
41.5
|
0.4
|
O
|
A:ILE164
|
3.3
|
37.3
|
1.0
|
C
|
A:ILE164
|
3.3
|
35.2
|
1.0
|
N5
|
A:NKE402
|
3.4
|
62.0
|
0.6
|
N
|
A:ASN117
|
3.4
|
46.7
|
1.0
|
OG1
|
A:THR119
|
3.5
|
43.2
|
1.0
|
N
|
A:ASP165
|
3.5
|
34.5
|
1.0
|
CB
|
A:ASN117
|
3.6
|
53.8
|
1.0
|
C
|
A:ASN117
|
3.7
|
48.0
|
1.0
|
N
|
A:ILE164
|
3.7
|
32.2
|
1.0
|
CA
|
A:ASN117
|
3.7
|
49.7
|
1.0
|
C
|
A:MET163
|
4.0
|
31.9
|
1.0
|
CA
|
A:ILE164
|
4.1
|
34.1
|
1.0
|
CB
|
A:MET163
|
4.1
|
34.4
|
1.0
|
CA
|
A:ASP165
|
4.1
|
36.8
|
1.0
|
CB
|
A:ASP165
|
4.1
|
39.3
|
1.0
|
C7
|
A:NKE402
|
4.2
|
62.7
|
0.6
|
C2
|
A:NKE402
|
4.2
|
61.5
|
0.6
|
O
|
A:THR119
|
4.2
|
36.8
|
1.0
|
ND2
|
A:ASN117
|
4.2
|
56.7
|
1.0
|
C
|
A:VAL116
|
4.2
|
43.5
|
1.0
|
CB
|
A:VAL116
|
4.3
|
42.7
|
1.0
|
CG
|
A:ASN117
|
4.3
|
58.0
|
1.0
|
O
|
A:HOH613
|
4.3
|
49.8
|
1.0
|
O
|
A:MET163
|
4.4
|
28.6
|
1.0
|
CA
|
A:MET163
|
4.5
|
32.0
|
1.0
|
CA
|
A:VAL116
|
4.5
|
41.8
|
1.0
|
N
|
A:THR119
|
4.6
|
42.2
|
1.0
|
N9
|
A:NKE402
|
4.7
|
62.0
|
0.6
|
C3
|
A:NKE402
|
4.7
|
63.5
|
0.6
|
CB
|
A:THR119
|
4.8
|
41.3
|
1.0
|
N
|
A:ASN118
|
4.9
|
48.8
|
1.0
|
|
Bromine binding site 6 out
of 6 in 6tlr
Go back to
Bromine Binding Sites List in 6tlr
Bromine binding site 6 out
of 6 in the Human CK2 Kinase Alpha Subunit in Complex with the Atp-Competitive Inhibitor 4,7-Dibromobenzotriazole
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 6 of Human CK2 Kinase Alpha Subunit in Complex with the Atp-Competitive Inhibitor 4,7-Dibromobenzotriazole within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Br402
b:78.7
occ:0.60
|
BR2
|
A:NKE402
|
0.0
|
78.7
|
0.6
|
C3
|
A:NKE402
|
1.9
|
63.5
|
0.6
|
C7
|
A:NKE402
|
2.8
|
62.7
|
0.6
|
C2
|
A:NKE402
|
2.9
|
61.5
|
0.6
|
NH2
|
A:ARG172
|
3.1
|
33.6
|
0.5
|
N8
|
A:NKE402
|
3.3
|
62.2
|
0.6
|
CZ
|
A:ARG172
|
3.3
|
31.7
|
0.5
|
NH1
|
A:ARG172
|
3.4
|
32.3
|
0.5
|
CB
|
A:LYS170
|
3.8
|
42.1
|
1.0
|
NE
|
A:ARG172
|
3.9
|
35.6
|
0.5
|
O
|
A:HOH796
|
4.0
|
74.6
|
1.0
|
CD
|
A:LYS170
|
4.0
|
54.0
|
1.0
|
NH1
|
A:ARG172
|
4.1
|
38.4
|
0.5
|
NE
|
A:ARG172
|
4.1
|
31.1
|
0.5
|
C6
|
A:NKE402
|
4.1
|
60.8
|
0.6
|
CG
|
A:LYS170
|
4.2
|
49.1
|
1.0
|
C1
|
A:NKE402
|
4.2
|
60.2
|
0.6
|
O
|
A:HOH714
|
4.2
|
33.0
|
0.5
|
O
|
A:HOH886
|
4.3
|
39.3
|
0.5
|
CZ
|
A:ARG172
|
4.4
|
37.9
|
0.5
|
O
|
A:HOH837
|
4.5
|
24.0
|
0.4
|
N9
|
A:NKE402
|
4.6
|
62.0
|
0.6
|
C4
|
A:NKE402
|
4.7
|
59.1
|
0.6
|
CG
|
A:ARG172
|
4.7
|
32.3
|
0.5
|
CG
|
A:ARG172
|
4.7
|
29.0
|
0.5
|
CD
|
A:ARG172
|
4.9
|
33.8
|
0.5
|
CD
|
A:ARG172
|
4.9
|
29.9
|
0.5
|
O
|
A:HOH801
|
5.0
|
60.6
|
1.0
|
|
Reference:
H.Czapinska,
A.Piasecka,
M.Winiewska-Szajewska,
M.Bochtler,
J.Poznanski.
Binding of Bromobenzotriazoles By the Catalytic Subunit of Human Protein Kinase CK2: Structural and Thermodynamics Studies. To Be Published.
Page generated: Thu Jul 11 02:44:24 2024
|